Litcius/Paper detail

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

Göran Dellgren, Thomas Kromann Lund, Peter Raivio, Inga Leuckfeld, J. Svahn, Erik Holmberg, Peter Skov Olsen, Maija Halme, Arnt E. Fiane, Sandra Lindstedt, Gerdt C. Riise, Jesper Magnusson

2023The Lancet Respiratory Medicine36 citationsDOI

Topics & Concepts

MedicineCiclosporinLung transplantationTacrolimusTransplantationCalcineurinImmunosuppressionClinical endpointAnti-thymocyte globulinPopulationSurgeryRandomized controlled trialInternal medicineEnvironmental healthTransplantation: Methods and OutcomesRenal Transplantation Outcomes and TreatmentsOrgan and Tissue Transplantation Research
Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial | Litcius